J0889 HCPCS Level II code: Daprodustat, oral, 1 mg, (for esrd on dialysis)
CMS terminated J0889: its last date of service was Dec 31, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
J0889Daprodustat, oral, 1 mg, (for esrd on dialysis)
Short description: Daprodustat oral 1mg esrd
HCPCS · United States
Medicare details
The indicators CMS publishes with J0889 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Other carrier priced
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Oct 1, 2023
- Terminated after
- Dec 31, 2025
Where J0889 sits
- 1J codesDrugs administered other than orally
- 2Terminated J0889Daprodustat, oral, 1 mg, (for esrd on dialysis)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J0889 still valid?
No. CMS terminated J0889; its last date of service was Dec 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J0889?
CMS lists J0889’s Medicare coverage as “Carrier judgment” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0889
All J codesJ0883Injection, argatroban, 1 mg (for non-esrd use)J0884Injection, argatroban, 1 mg (for esrd on dialysis)J0885Injection, epoetin alfa, (for non-esrd use), 1000 unitsJ0886Injection, epoetin alfa, 1000 units (for esrd on dialysis)J0887Injection, epoetin beta, 1 microgram, (for esrd on dialysis)J0888Injection, epoetin beta, 1 microgram, (for non esrd use)J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mgJ0894Injection, decitabine, 1 mgJ0895Injection, deferoxamine mesylate, 500 mg